Hearing Outcomes with Percutaneous and Transcutaneous BAHA® Technology in Conductive and Mixed Hearing Loss.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
entrez:
16
9
2021
pubmed:
17
9
2021
medline:
8
10
2021
Statut:
ppublish
Résumé
To evaluate outcomes of BAHA Connect® and BAHA Attract® implantations, and to examine the prognostic utility of a preimplantation Softband®-attached processor trial. Retrospective case review. Tertiary referral center. Patients who underwent Connect® (19 ears) and Attract® (25 ears) implantation between 2007 and 2017. BAHA® implantation. Unaided air conduction (AC), bone conduction (BC), and speech reception thresholds (SRTs), as well as free field (FF) aided with Softband®-attached processor and with implant-attached processor thresholds. Serviceable implant-attached processor PTA0.5,1,2 kHz (≤35 dB HL) was achieved in 89 and 88% of the Connect® and the Attract® ears, respectively, while at 4 kHz this was achieved in 68 and 32% of the Connect® and the Attract® ears, respectively (p = 0.032). Significantly more Connect® ears showed alignment between FF aided with implant-attached processors thresholds and BC thresholds. The alignment between the Softband®-attached processors thresholds and implant-attached processors thresholds was similar in the two groups. Both groups exhibited similar positive improvement in the quality of life questionnaires. Accessibility to sound with the implant-attached processor is well predicted by the pre-implantation Softband® trial, both in the BAHA Connect® and in the BAHA Attract® ears. Hearing rehabilitation targets at 0.5, 1, and 2 kHz are met by most Connect® and Attract® ears, while at 4 kHz the outcome with Attract® is poorer. This information should be presented to the patient during consultation prior to a decision as to the type of BAHA® device to be implanted.
Identifiants
pubmed: 34528924
doi: 10.1097/MAO.0000000000003231
pii: 00129492-202110000-00030
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1382-1389Informations de copyright
Copyright © 2021, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
The authors disclose no conflicts of interest.
Références
Rainsbury JW, Williams BA, Gulliver M, Morris DP. Preoperative headband assessment for semi-implantable bone conduction hearing devices in conductive hearing loss: Is it useful or misleading? Otol Neurotol 2015; 36:e58–e62.
Rasmussen J, Olsen SO, Nielsen LH. Evaluation of long-term patient satisfaction and experience with the Baha(R) bone conduction implant. Int J Audiol 2012; 51:194–199.
Saroul N, Gilain L, Montalban A, Giraudet F, Avan P, Mom T. Patient satisfaction and functional results with the bone-anchored hearing aid (BAHA). Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128:107–113.
Badran K, Bunstone D, Arya AK, Suryanarayanan R, Mackinnon N. Patient satisfaction with the bone-anchored hearing aid: a 14-year experience. Otol Neurotol 2006; 27:659–666.
Arunachalan, Kilby, Meikle, Davison, Johnson. Bone-anchored hearing aid: quality of life assess by Glasgow benefit inventory. Clin Otolaryngol Allied Sci 2000; 25:570–576.
Ho EC, Monksfield P, Egan E, Reid A, Proops D. Bilateral bone-anchored hearing aid: impact on quality of life measured with the Glasgow Benefit Inventory. Otol Neurotol 2009; 30:891–896.
Gerdes T, Salcher RB, Schwab B, Lenarz T, Maier H. Comparison of audiological results between a transcutaneous and a percutaneous bone conduction instrument in conductive hearing loss. Otol Neurotol 2016; 37:685–691.
Arndt S, Kromeier J, Berlis A, Maier W, Laszig R, Aschendorff A. Imaging procedures after bone-anchored hearing aid implantation. Laryngoscope 2007; 117:1815–1818.
Kiringoda R, Lustig LR. A meta-analysis of the complications associated with osseointegrated hearing aids. Otol Neurotol 2013; 34:790–794.
Reinfeldt S, Håkansson B, Taghavi H, Eeg-Olofsson M. New developments in bone-conduction hearing implants: a review. Med Devices Evid Res 2015; 8:79–93.
CochlearTM Baha® Systems Candidate Selection Guide © Cochlear Bone Anchored Solutions AB, 2017.
Nevoux J, Coudert C, Boulet M, et al. Transcutaneous BAHA attract system: long-term outcomes of the French multicenter study. Clin Otolaryngol 2018; 43:1553–1559.
Dimitriadis PA, Farr MR, Allam A, Ray J. Three year experience with the cochlear BAHA attract implant: a systematic review of the literature. BMC Ear Nose Throat Disord 2016; 16:1–8.
Hol MKS, Nelissen RC, Agterberg MJH, Cremers CWRJ, Snik AFM. Comparison between a new implantable transcutaneous bone conductor and percutaneous bone-conduction hearing implant. Otol Neurotol 2013; 34:1071–1075.
Håkansson B, Tjellström a, Carlsson P. Percutaneous vs. transcutaneous transducers for hearing by direct bone conduction. Otolaryngol Head Neck Surg 1990; 102:339–344.
Briggs R, Van Hasselt A, Luntz M, et al. Clinical performance of a new magnetic bone conduction hearing implant system: results from a prospective, multicenter, clinical investigation. Otol Neurotol 2015; 36:834–841.
Hougaard DD, Boldsen SK, Jensen AM, Hansen S, Thomassen PC. A multicenter study on objective and subjective benefits with a transcutaneous bone-anchored hearing aid device: first Nordic results. Eur Arch Oto-Rhino-Laryngol 2017; 274:3011–3019.
Verstraeten N, Zarowski AJ, Somers T, Riff D, Offeciers EF. Comparison of the audiologic results obtained with the bone-anchored hearing aid attached to the headband, the testband, and to the “snap” abutment. Otol Neurotol 2009; 30:70–75.
Ihler F, Blum J, Berger MU, Weiss BG, Welz C, Canis M. The prediction of speech recognition in noise with a semi-implantable bone conduction hearing system by external bone conduction stimulation with headband: a prospective study. Trends Hear 2016; 20:1–12.
Monini S, Filippi C, Atturo F, Biagini M, Lazzarino AI, Barbara M. Individualised headband simulation test for predicting outcome after percutaneous bone conductive implantation. Acta Otorhinolaryngol Ital 2015; 35:258–264.
den Besten CA, Monksfield P, Bosman A, et al. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: six-month results from a multicentre study. Clin Otolaryngol 2019; 44:144–157.
Shin JW, Kim SH, Choi JY, et al. Surgical and audiologic comparison between sophono and bone-anchored hearing aids implantation. Clin Exp Otorhinolaryngol 2016; 9:21–26.
Rigato C, Reinfeldt S, Håkansson B, Jansson K-JF, Hol MKS, Eeg-Olofsson M. Audiometric comparison between the first patients with the transcutaneous bone conduction implant and matched percutaneous bone anchored hearing device users. Otol Neurotol 2016; 37:1381–1387.
Iseri M, Orhan KS, Tuncer U, et al. Transcutaneous bone-anchored hearing aids versus percutaneous ones: multicenter comparative clinical study. Otol Neurotol 2015; 36:849–853.
Robinson K, Gathehouse S, Gg B. Measuring patient benefit from otorhinolaryncological surgery and therapy. Ann Otol Rhinol Laryngol 1996; 105:415–422.
Kubba H, Swan IRC, Gatehouse S. The Glasgow Children's Benefit Inventory: a new instrument for assessing health-related benefit after an intervention. Ann Otol Rhinol Laryngol 2004; 113:980–986.
Brackmann DE, Owens RM, Friedman RA, et al. Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000; 21:417–424.
Woodson EA, Dempewolf RD, Gubbels SP, et al. Long-term hearing preservation after microsurgical excision of vestibular schwannoma. Otol Neurotol 2010; 31:1144–1152.
Carlson ML, Jacob JT, Pollock BE, et al. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg 2013; 118:579–587.
Olsen WO. Average speech levels and spectra in various speaking/listening conditions. Am J Audiol 1998; 7:21–25.
Hultcrantz M. Outcome of the bone-anchored hearing aid procedure without skin thinning: a prospective clinical trial. Otol Neurotol 2011; 32:1134–1139.
Lekue A, Lassaletta L, Sanchez-Camon I, Perez-Mora R, Gavilan J. Quality of life in patients implanted with the BAHA device depending on the aetiology. Acta Otorrinolaringol Esp 2013; 64:17–21. doi:10.1016/j.otorri.2012.06.006.
doi: 10.1016/j.otorri.2012.06.006
Luntz M, Yehudai N, Haifler M, et al. Risk factors for sensorineural hearing loss in chronic otitis media risk factors for sensorineural hearing loss in chronic otitis media 2013; 6489doi:10.3109/00016489.2013.814154.
doi: 10.3109/00016489.2013.814154
Yehudai N, Most T, Luntz M. Risk factors for sensorineural hearing loss in pediatric chronic otitis media. Int J Pediatr Otorhinolaryngol 2015; 79:26–30.
Kim JS, Kim CH. A review of assistive listening device and digital wireless technology for hearing instruments. Korean J Audiol 2014; doi:10.7874/kja.2014.18.3.105.
doi: 10.7874/kja.2014.18.3.105
De Wolf MJF, Shival MLC, Hol MKS, Mylanus EAM, Cremers CWRJ, Snik AFM. Benefit and quality of life in older bone-anchored hearing aid users. Otol Neurotol 2010; 31:766–772.
Moore BCJ, Moore BCJ. A review of the perceptual effects of hearing loss for frequencies above 3 kHz above 3 kHz 2016; 2027doi:10.1080/14992027.2016.1204565.
doi: 10.1080/14992027.2016.1204565
Rosemann S, Thiel CM. The effect of age-related hearing loss and listening effort on resting state connectivity. Sci Rep 2019; 9:1–9.
Flynn MC, Hedin A, Halvarsson G, Good T, Sadeghi A. Hearing performance benefits of a programmable power BAHA ( sound processor with a directional microphone for patients with a mixed hearing loss. In: Clinical and Experimental Otorhinolaryngology Vol 5, 2012. doi:10.3342/ceo.2012.5.S1.S76
Kunst SJW, Hol MKS, Mylanus EaM, Leijendeckers JM, Snik AFM, Cremers CWRJ. Subjective benefit after BAHA system application in patients with congenital unilateral conductive hearing impairment. Otol Neurotol 2008; 29:353–358.
McDermott A-L, Williams J, Kuo M, Reid A, Proops D. Quality of life in children fitted with a bone-anchored hearing aid. Otol Neurotol 2009; 30:344–349.